靶向黄褐斑中导致黑素细胞过度活跃的衰老真皮成纤维细胞。 - Suppr

Suppr

超能文献

Targeting senescent dermal fibroblasts responsible for hyperactive melanocytes in melasma.

作者信息

Wan Jing, Liao Zhikai, Dong Bingqi, Jiang Shan, Lei Tiechi

机构信息

Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.

出版信息

Chin Med J (Engl). 2023 Jul 5;136(13):1563-1565. doi: 10.1097/CM9.0000000000002488.

DOI:10.1097/CM9.0000000000002488

PMID:37057732

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10325758/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c3/10325758/337ca1582a6d/cm9-136-1563-g001.jpg

相似文献

Targeting senescent dermal fibroblasts responsible for hyperactive melanocytes in melasma.

Chin Med J (Engl). 2023 Jul 5;136(13):1563-1565. doi: 10.1097/CM9.0000000000002488.

Role of fibroblast-derived factors in the pathogenesis of melasma.

Clin Exp Dermatol. 2016 Aug;41(6):601-9. doi: 10.1111/ced.12874.

Senescent fibroblasts in melasma pathophysiology.

Exp Dermatol. 2019 Jun;28(6):719-722. doi: 10.1111/exd.13814. Epub 2018 Dec 21.

Expression of OPN3 in fibroblasts, melanocytes, and keratinocytes of skin with facial melasma in comparison with unaffected adjacent skin.

An Bras Dermatol. 2021 May-Jun;96(3):367-369. doi: 10.1016/j.abd.2020.05.016. Epub 2021 Mar 15.

Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma.

J Invest Dermatol. 2013 Jan;133(1):191-200. doi: 10.1038/jid.2012.270. Epub 2012 Sep 6.

Future therapies in melasma: What lies ahead?

Indian J Dermatol Venereol Leprol. 2020 Jan-Feb;86(1):8-17. doi: 10.4103/ijdvl.IJDVL_633_18.

Fibroblast morphology, growth rate and gene expression in facial melasma.

An Bras Dermatol. 2022 Sep-Oct;97(5):575-582. doi: 10.1016/j.abd.2021.09.012. Epub 2022 Jul 12.

Melasma: histopathological characteristics in 56 Korean patients.

Br J Dermatol. 2002 Feb;146(2):228-37. doi: 10.1046/j.0007-0963.2001.04556.x.

Cadherin 11 Involved in Basement Membrane Damage and Dermal Changes in Melasma.

Acta Derm Venereol. 2016 Jun 15;96(5):635-40. doi: 10.2340/00015555-2315.

Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma.

Pigment Cell Melanoma Res. 2021 Nov;34(6):1105-1111. doi: 10.1111/pcmr.12984. Epub 2021 May 28.

引用本文的文献

Clinical Efficacy of CGF Combined With Periodic Supramolecular Salicylic Acid in the Treatment of Chloasma.

J Cosmet Dermatol. 2025 Apr;24(4):e70146. doi: 10.1111/jocd.70146.

Pathogenesis of Melasma Explained.

Int J Dermatol. 2025 Jul;64(7):1201-1212. doi: 10.1111/ijd.17718. Epub 2025 Feb 28.

Assessment of clinical efficacy in melasma treatment with picosecond laser combined with Shumin Star.

Arch Dermatol Res. 2025 Feb 14;317(1):406. doi: 10.1007/s00403-025-03944-2.

本文引用的文献

Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.

Dermatol Ther (Heidelb). 2022 Jun;12(6):1325-1336. doi: 10.1007/s13555-022-00728-8. Epub 2022 May 11.

Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.

J Am Acad Dermatol. 2023 Feb;88(2):271-288. doi: 10.1016/j.jaad.2022.01.051. Epub 2022 Feb 11.

Dermal Pathology in Melasma: An Update Review.

Clin Cosmet Investig Dermatol. 2022 Jan 6;15:11-19. doi: 10.2147/CCID.S343332. eCollection 2022.

A Clinical and Biochemical Evaluation of a Temperature-Controlled Continuous Non-Invasive Radiofrequency Device for the Treatment of Melasma.

Ann Dermatol. 2021 Dec;33(6):522-530. doi: 10.5021/ad.2021.33.6.522. Epub 2021 Nov 4.

The potential skin-lightening candidate, senolytic drug ABT263, for photoageing pigmentation.

Br J Dermatol. 2022 Apr;186(4):740-742. doi: 10.1111/bjd.20893. Epub 2022 Jan 20.

A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.

Arch Dermatol Res. 2022 Oct;314(8):791-797. doi: 10.1007/s00403-021-02294-z. Epub 2021 Oct 27.

Melasma treatment: a systematic review.

J Dermatolog Treat. 2022 Jun;33(4):1816-1837. doi: 10.1080/09546634.2021.1914313. Epub 2022 Mar 23.

The efficacy of energy-based devices combination therapy for melasma.

Dermatol Ther. 2021 May;34(3):e14927. doi: 10.1111/dth.14927. Epub 2021 Mar 18.

Epilipidomics of Senescent Dermal Fibroblasts Identify Lysophosphatidylcholines as Pleiotropic Senescence-Associated Secretory Phenotype (SASP) Factors.

J Invest Dermatol. 2021 Apr;141(4S):993-1006.e15. doi: 10.1016/j.jid.2020.11.020. Epub 2020 Dec 15.

Tranexamic Acid Inhibits Angiogenesis and Melanogenesis by Targeting VEGF Receptors.

Int J Med Sci. 2020 Mar 25;17(7):903-911. doi: 10.7150/ijms.44188. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Targeting senescent dermal fibroblasts responsible for hyperactive melanocytes in melasma.

Chin Med J (Engl). 2023 Jul 5;136(13):1563-1565. doi: 10.1097/CM9.0000000000002488.

Role of fibroblast-derived factors in the pathogenesis of melasma.

Clin Exp Dermatol. 2016 Aug;41(6):601-9. doi: 10.1111/ced.12874.

Senescent fibroblasts in melasma pathophysiology.

Exp Dermatol. 2019 Jun;28(6):719-722. doi: 10.1111/exd.13814. Epub 2018 Dec 21.

Expression of OPN3 in fibroblasts, melanocytes, and keratinocytes of skin with facial melasma in comparison with unaffected adjacent skin.

An Bras Dermatol. 2021 May-Jun;96(3):367-369. doi: 10.1016/j.abd.2020.05.016. Epub 2021 Mar 15.

Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma.

J Invest Dermatol. 2013 Jan;133(1):191-200. doi: 10.1038/jid.2012.270. Epub 2012 Sep 6.

Future therapies in melasma: What lies ahead?

Indian J Dermatol Venereol Leprol. 2020 Jan-Feb;86(1):8-17. doi: 10.4103/ijdvl.IJDVL_633_18.

Fibroblast morphology, growth rate and gene expression in facial melasma.

An Bras Dermatol. 2022 Sep-Oct;97(5):575-582. doi: 10.1016/j.abd.2021.09.012. Epub 2022 Jul 12.

Melasma: histopathological characteristics in 56 Korean patients.

Br J Dermatol. 2002 Feb;146(2):228-37. doi: 10.1046/j.0007-0963.2001.04556.x.

Cadherin 11 Involved in Basement Membrane Damage and Dermal Changes in Melasma.

Acta Derm Venereol. 2016 Jun 15;96(5):635-40. doi: 10.2340/00015555-2315.

Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma.

Pigment Cell Melanoma Res. 2021 Nov;34(6):1105-1111. doi: 10.1111/pcmr.12984. Epub 2021 May 28.

引用本文的文献

Clinical Efficacy of CGF Combined With Periodic Supramolecular Salicylic Acid in the Treatment of Chloasma.

J Cosmet Dermatol. 2025 Apr;24(4):e70146. doi: 10.1111/jocd.70146.

Pathogenesis of Melasma Explained.

Int J Dermatol. 2025 Jul;64(7):1201-1212. doi: 10.1111/ijd.17718. Epub 2025 Feb 28.

Assessment of clinical efficacy in melasma treatment with picosecond laser combined with Shumin Star.

Arch Dermatol Res. 2025 Feb 14;317(1):406. doi: 10.1007/s00403-025-03944-2.

本文引用的文献

Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.

Dermatol Ther (Heidelb). 2022 Jun;12(6):1325-1336. doi: 10.1007/s13555-022-00728-8. Epub 2022 May 11.

Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.

J Am Acad Dermatol. 2023 Feb;88(2):271-288. doi: 10.1016/j.jaad.2022.01.051. Epub 2022 Feb 11.

Dermal Pathology in Melasma: An Update Review.

Clin Cosmet Investig Dermatol. 2022 Jan 6;15:11-19. doi: 10.2147/CCID.S343332. eCollection 2022.

A Clinical and Biochemical Evaluation of a Temperature-Controlled Continuous Non-Invasive Radiofrequency Device for the Treatment of Melasma.

Ann Dermatol. 2021 Dec;33(6):522-530. doi: 10.5021/ad.2021.33.6.522. Epub 2021 Nov 4.

The potential skin-lightening candidate, senolytic drug ABT263, for photoageing pigmentation.

Br J Dermatol. 2022 Apr;186(4):740-742. doi: 10.1111/bjd.20893. Epub 2022 Jan 20.

A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.

Arch Dermatol Res. 2022 Oct;314(8):791-797. doi: 10.1007/s00403-021-02294-z. Epub 2021 Oct 27.

Melasma treatment: a systematic review.

J Dermatolog Treat. 2022 Jun;33(4):1816-1837. doi: 10.1080/09546634.2021.1914313. Epub 2022 Mar 23.

The efficacy of energy-based devices combination therapy for melasma.

Dermatol Ther. 2021 May;34(3):e14927. doi: 10.1111/dth.14927. Epub 2021 Mar 18.

Epilipidomics of Senescent Dermal Fibroblasts Identify Lysophosphatidylcholines as Pleiotropic Senescence-Associated Secretory Phenotype (SASP) Factors.

J Invest Dermatol. 2021 Apr;141(4S):993-1006.e15. doi: 10.1016/j.jid.2020.11.020. Epub 2020 Dec 15.

Tranexamic Acid Inhibits Angiogenesis and Melanogenesis by Targeting VEGF Receptors.

Int J Med Sci. 2020 Mar 25;17(7):903-911. doi: 10.7150/ijms.44188. eCollection 2020.